Back to company

Afyx Development A/S: Financial statements 2022

CVR: 35839739

Afyx Development A/S (CVR 35839739) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -8,601,049 and a net result of DKK -24,274,950 compared with DKK -35,049,956 the year before. Equity amounted to DKK -112,308,790. The company had 3 employees in the financial year.

Gross Profit
-8,601,049 kr.
Profit/Loss
-24,274,950 kr.
Equity
-112,308,790 kr.
Total Assets
16,263,761 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--8.6 mio.-24.3 mio.-112.3 mio.3
2021--27.4 mio.-35 mio.-88 mio.6
2020--36.2 mio.-49.5 mio.-53 mio.10
2019--52.5 mio.-57.7 mio.-3.5 mio.10
2018--37.6 mio.-45.1 mio.54.2 mio.8

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Afyx Development A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Afyx Development A/S: The 2021 annual report is outJun 29, 2022

Afyx Development A/S has published its annual report for 2021. Gross profit came to DKK -27,442,244, and the net result was DKK -35,049,956.

Nishan de Silva leaves the board of Afyx Development A/SFeb 22, 2022

As of February 22, 2022, Nishan de Silva has left the board of directors of Afyx Development A/S.

Lars Siim Madsen joins Afyx Development A/S as adm. dir.Feb 22, 2022

As of February 22, 2022, Lars Siim Madsen is registered as adm. dir. of Afyx Development A/S.

Nishan de Silva steps down as adm. dir. of Afyx Development A/SFeb 22, 2022

As of February 22, 2022, Nishan de Silva has stepped down as adm. dir. of Afyx Development A/S.

About Afyx Development A/S

Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The company is owned by Afyx Therapeutics A/S. The company has 8 employees. In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity amounted to DKK -7,253,987.